Cell differentiation promotion via transfer of regulatory RNAs and proteins to recipient cells

The phrase "Cell differentiation promotion via transfer of regulatory RNAs/proteins to recipient cells" describes a **biological process** rather than an individual molecule or canonical therapeutic target. This process involves the movement of regulatory molecules—such as RNA-binding proteins, microRNAs, long non-coding RNAs, and other protein factors—from one cell to another. These transferred molecules can modulate gene expression post-transcriptionally in recipient cells, thereby influencing their fate and promoting processes such as stem cell maintenance or directed differentiation[1][2]. For example, RNA-binding proteins like FMRP regulate mRNA translation and interact with miRNA machinery critical for stem cell function[1], while complexes like the RNA exosome degrade specific transcripts to maintain pluripotency or trigger differentiation[2]. Regulatory RNAs also play key roles in sculpting gene expression during development by silencing or activating specific genes through mechanisms such as RNA interference[3]. This entry does **not correspond to an individual protein/receptor/enzyme/transporter**, but instead refers broadly to intercellular communication mechanisms that govern cellular identity. As such, it cannot be classified under standard molecular families nor directly targeted by drugs. If you are seeking information on specific molecules involved in this process—such as Argonaute proteins for miRNA-mediated silencing[3], FMRP for translational repression[1], or components of the exosome complex like EXOSC3/EXOSC9/DIS3 for RNA degradation[2]—those should be listed individually. In summary: > The provided name describes a general mechanism/process involving multiple classes of regulatory molecules that mediate cell fate decisions through intercellular transfer; it is not itself an actionable therapeutic target nor does it have standard aliases or abbreviations.[1][2][3]